Skip to main content
. 2023 Dec 16;72(4):491–506. doi: 10.33073/pjm-2023-048

Table IV.

Results of susceptibility testing to amikacin and clarithromycin obtained by manually conducted microdilution method. Interpretation criteria following CLSI.

No. Species AN Interpretation* CLA after 5 days of incubation Interpretation* CLA after 14 days of incubation Interpretation*
1 Mabs 16 (S) 0.06 (S) 0,5 (S)
2 Mabs 8 (S) 0.06 (S) > 64 (R)
3 Mabs 16 (S) 0.06 (S) = 32 (R)
4 Mabs 16 (S) 0.06 (S) = 32 (R)
5 Mabs 16 (S) 0.06 (S) = 32 (R)
6 Mabs 16 (S) 0.06 (S) = 32 (R)
7 Mmas
8 Mmas 16 (S) 0.06 (S) = 0.125 (S)
9 Mabs 16 (S) 0.06 (S) = 0.125 (S)
10 Mmas 16 (S) 0.06 (S) = 0.06 (S)
11 Mbol 0.5 (S) 0.06 (S) > 64 (R)
12 Mabs 0.250 (S) 4 (R) = 16 (R)
1

Mabs – Mycobacterium abscessus subsp. Abscessus, Mmas – Mycobacterium abscessus subsp. massiliense, Mbol – Mycobacterium abscessus subsp. bolletii

1

S – susceptible, I – intermediate, R – resistant

1

AN – amikacin, CLA – clarithromycin

1

* – interpretation of the result was done according CLSI